TipRanks
Go Ultimate55% OFF

Clorox (CLX) Price & Analysis

CLX Stock Chart & Stats

MX$1,675.00MX$8.00(0.48%)
At close: 4:00 PM EDT
MXN 1,500MXN 1,600MXN 1,700MXN 1,8004 Aug7 Aug1 Sep15 Sep29 Sep13 Oct27 Oct
Day’s Range
MXN 1,675.00 - MXN 1,675.00
52-Week Range
MXN 1,440.00 - MXN 2,500.00
Previous Close
MXN 1,667.00
Volume
0
Average Volume (3M)
118
Market Cap
MXN 199.93B
Enterprise Value
MXN 17.23B
Total Cash (Recent Filing)
MXN 143.00M
Total Debt (Recent Filing)
MXN 5.52B
Price to Earnings (P/E)
18.3
Beta
0.66
Next Earnings
Nov 02, 2026
Next Dividend Ex-Date
N/A
Dividend Yield
5.53%

Bulls Say, Bears Say

Bulls Say

Market Share Momentum

Repeated share gains across Home Care, Pro and International indicate that Clorox retains meaningful brand equity and retailer relevance. This supports durable distribution, repeat purchasing and pricing power, while the breadth of gains reduces reliance on a single product category.

GOJO Strategic Expansion

The GOJO acquisition expands Clorox’s health and hygiene platform through PURELL and is already reported as accretive. Expected mid-single-digit growth and additional revenue synergies could broaden the portfolio and create a durable source of incremental earnings.

Positive Free Cash Flow

Consistently positive free cash flow, including $405 million in 2026, shows that Clorox continues to convert operations into cash despite earnings volatility. This supports dividends, brand investment and integration spending, although leverage makes disciplined cash allocation especially important.

Bears Say

Extreme Leverage

Clorox’s debt-heavy capital structure leaves a very small equity cushion relative to $5.52 billion of debt. That magnifies the effect of earnings swings, raises refinancing exposure and limits flexibility to invest, absorb setbacks or pursue growth without prioritizing balance-sheet repair.

Revenue And Margin Volatility

The sharp 2026 top-line decline and renewed margin contraction weaken confidence in the durability of Clorox’s earnings base. Continued volatility can reduce operating leverage, constrain reinvestment and make it harder for the company to generate consistent returns while it rebuilds sales momentum.

Inflation And Promotion Pressure

Inflation above $200 million and sustained promotional intensity create a structural challenge for gross margin and brand economics. Pricing and productivity actions may offset part of the pressure, but persistent cost increases and heavier promotions can weaken profitability and limit cash available for growth.

Clorox News

CLX FAQ

What was Clorox’s price range in the past 12 months?
Clorox lowest stock price was Mex$1440.00 and its highest was Mex$2500.00 in the past 12 months.
What is Clorox’s market cap?
Clorox’s market cap is Mex$199.93B.
When is Clorox’s upcoming earnings report date?
Clorox’s upcoming earnings report date is Nov 02, 2026 which is in 1 day.
How were Clorox’s earnings last quarter?
Clorox released its earnings results on Aug 03, 2026. The company reported Mex$31.185 earnings per share for the quarter, beating the consensus estimate of Mex$30.828 by Mex$0.357.
Is Clorox overvalued?
According to Wall Street analysts Clorox’s price is currently Undervalued.
Does Clorox pay dividends?
Clorox does not currently pay dividends.
What is Clorox’s EPS estimate?
Clorox’s EPS estimate is 20.14.
How many shares outstanding does Clorox have?
Clorox has 120,938,190 shares outstanding.
What happened to Clorox’s price movement after its last earnings report?
Clorox reported an EPS of Mex$31.185 in its last earnings report, beating expectations of Mex$30.828. Following the earnings report the stock price went up 6.805%.
Which hedge fund is a major shareholder of Clorox?
Currently, no hedge funds are holding shares in MX:CLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology